Park Hyun J, Brooks Daniel I, Chavarria Christopher S, Wu Richard L, Mikita Cecilia P, Beakes Douglas E
Department of Allergy and Immunology, Walter Reed National Military Medical Center, Bethesda, Md.
Department of Research Programs, Walter Reed National Military Medical Center, Bethesda, Md.
J Allergy Clin Immunol Pract. 2022 Mar;10(3):837-843.e3. doi: 10.1016/j.jaip.2021.08.037. Epub 2021 Sep 14.
Diagnosis of patients with hymenoptera venom hypersensitivity consists of elucidating clinical symptoms suggestive of systemic reaction (SR) and then confirmation of sensitization via intradermal skin testing (IDST) first and serum IgE assays such as ImmunoCAP (ICAP) as a complementary modality of diagnosis.
Determine the concordance between ICAP and IDST in patients with a clinical history suggestive of hymenoptera venom SR. Determine whether venom immunotherapy would change on the basis of IDST versus ICAP results.
A prospective diagnostic study was designed to test the concordance between IDST and ICAP venom testing in the diagnosis of hymenoptera venom hypersensitivity. This study entailed testing both IDST and ICAP for 5 hymenoptera venoms (honey bee, wasp, yellow jacket, yellow hornet, and white-faced hornet) in both a case group with SR to hymenoptera venom (N = 70) and a control group without SR (N = 51).
Significant discordance was observed between positive IDST and ICAP results for any of the 5 hymenoptera venoms (McNemar test, P = .001). In the case group, there was significant discordance for wasp (P < .0001), yellow jacket (P = .002), and white-faced hornet (P = .02). More than 47% of the case patients would have different venom immunotherapy prescriptions if ICAP and IDST had been performed during initial diagnosis versus IDST alone.
Our study shows significant discordance between IDST and ICAP; however, they are complementary. On the basis of our data, we propose ICAP testing first followed by IDST for ICAP-negative venoms as an alternative and efficient diagnostic strategy.
膜翅目毒液过敏患者的诊断包括明确提示全身反应(SR)的临床症状,然后首先通过皮内皮肤试验(IDST)确认致敏情况,并将血清IgE检测(如免疫化学发光法(ICAP))作为诊断的补充手段。
确定有膜翅目毒液SR临床病史患者中ICAP与IDST之间的一致性。确定毒液免疫疗法是否会根据IDST与ICAP的结果而改变。
设计一项前瞻性诊断研究,以测试IDST与ICAP毒液检测在膜翅目毒液过敏诊断中的一致性。本研究对5种膜翅目毒液(蜜蜂、黄蜂、黄胡蜂、大黄蜂和白脸胡蜂)进行IDST和ICAP检测,研究对象包括有膜翅目毒液SR的病例组(N = 70)和无SR的对照组(N = 51)。
5种膜翅目毒液中任何一种的IDST阳性结果与ICAP结果之间均观察到显著不一致(McNemar检验,P = .001)。在病例组中,黄蜂(P < .0001)、黄胡蜂(P = .002)和白脸胡蜂(P = .02)存在显著不一致。如果在初始诊断时同时进行ICAP和IDST而非仅进行IDST,超过47%的病例患者会有不同的毒液免疫疗法处方。
我们的研究显示IDST与ICAP之间存在显著不一致;然而,它们具有互补性。根据我们的数据,我们建议首先进行ICAP检测,然后对ICAP阴性的毒液进行IDST检测,作为一种替代且有效的诊断策略。